Project Oncology® - Programs - Prova Education

Episodes 1-16 of 17

- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
5
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
8
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Ca...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
6
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
14
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
10
CME/CE
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
8
CME/CE
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
6
CME/CE
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
0.25 credits
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
5
CME/CE
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
0.25 credits
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
4
CME/CE
Keeping Pace: The Role of Immunotherapy After Disease Progression
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
- Warner K. Huh, MD
  Peer
- Deborah K. Armstrong, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
13
CME/CE
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
- Mark A. Socinski, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
7
CME/CE
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
- Peter H. O'Donnell, MD
  Peer
- Daniel P. Petrylak, MD
  Peer
13
CME/CE
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
0.25 credits
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
0.25 credits
- Mark A. Socinski, MD
  Peer
2
CME/CE
Key Highlights from the Latest Clinical Trials in Lung Cancer
Key Highlights from the Latest Clinical Trials in Lung Cancer
0.25 credits
Key Highlights from the Latest Clinical Trials in Lung Cancer
0.25 credits
3
FDA Drug Information Updates
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
- Shira Johnson, MD
  Peer
- Robert Vonderheide, MD
  Peer
25
Medical Breakthroughs from Penn Medicine
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
- John J. Russell, MD
  Peer
- Harish Lavu, MD
  Peer
10
Project Oncology®
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Pancreatic Cancer: The Hunt to Catch a Silent Killer

Prev
1
2
Next

1/2